Yew Bio-Pharm Group Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,439.60
7,726.60
29,573.80
51,348.10
40,539.70
37,596.90
Cost of Goods Sold (COGS) incl. D&A
2,564.10
2,269.40
22,636.60
48,185.20
35,506.50
26,872.70
Gross Income
4,875.50
5,457.20
6,937.20
3,162.90
5,033.20
10,724.20
SG&A Expense
977.80
1,171.20
1,797.20
1,041.50
1,708.50
10,005.70
EBIT
3,897.70
4,286.00
5,139.90
2,121.40
3,324.70
718.60
Non Operating Income/Expense
1.40
2.00
0.10
44.40
114.00
253.70
Interest Expense
-
-
121.20
140.80
225.00
294.10
Pretax Income
3,899.70
4,284.20
5,301.10
2,024.90
3,213.60
170.70
Income Tax
-
-
16.50
18.00
0.60
1,493.20
Consolidated Net Income
3,899.70
4,284.20
5,284.60
2,006.90
3,213.00
1,322.40
Net Income
3,899.70
4,284.20
5,284.60
2,006.90
3,213.00
1,322.40
Net Income After Extraordinaries
3,899.70
4,284.20
5,284.60
2,006.90
3,213.00
1,322.40
Net Income Available to Common
3,899.70
4,284.20
5,284.60
2,006.90
3,213.00
1,322.40
EPS (Basic)
0.08
0.08
0.10
0.04
0.06
0.03
Basic Shares Outstanding
50,000.00
50,949.00
52,069.90
51,875.00
51,875.00
51,965.40
EPS (Diluted)
0.08
0.07
0.10
0.04
0.06
0.03
Diluted Shares Outstanding
50,000.00
62,795.70
52,113.80
51,875.00
53,934.50
51,965.40
EBITDA
4,459.30
4,968.80
12,882.50
11,052.70
3,392.40
793.60
Non-Operating Interest Income
0.60
0.20
-
-
-
-
About Yew Bio-Pharm Group
View Profile
